Overview

Interval Intraocular Pressure in Intravitreal Injection Study

Status:
Completed
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
This is a prospective study of IOP in Intravitreal injections to evaluate: 1. IOP effect of intravitreal injection 2. IOP response to prophylactic beta blocker or Prostaglandin vs control (Hypromellose) over multiple time periods 3. IOP response in correlation to number of injections, IOL, type of anti VEGF, co morbidities
Phase:
N/A
Details
Lead Sponsor:
The University of Hong Kong
Treatments:
Timolol
Travoprost